References
- Egan TK. Monitoring patients undergoing cancer therapy. Lab Med. [Internet]. 2000 [cited 2018 Dec 1];31:666–671.
- Graham LJ, Shupe MP, Schneble EJ, et al. Current approaches and challenges in monitoring treatment responses in breast cancer. J Cancer. [Internet]. 2014 [cited 2019 Aug 23];5:58–68. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24396498
- Neal RD, Tharmanathan P, France B, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015 cited 2019 Aug 2;112(Suppl):S92–S107. [Internet]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25734382
- Car LT, Papachristou N, Urch C, et al. Preventing delayed diagnosis of cancer: clinicians’ views on main problems and solutions. J Glob Health. [Internet]. 2016 [cited 2019 Aug 2];6:020901. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28028437
- Cassim S, Chepulis L, Keenan R, et al. Patient and carer perceived barriers to early presentation and diagnosis of lung cancer: a systematic review. BMC Cancer. [Internet]. 2019 [cited 2019 Aug 2];19:25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30621616
- Huang T, Deng C-X. Current progresses of exosomes as cancer diagnostic and prognostic biomarkers. Int J Biol Sci. [Internet]. 2019 [cited 2019 Aug 2];15:1–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30662342
- Soung YH, Ford S, Zhang V, et al. Exosomes in cancer diagnostics [Internet]. 2017 [cited 2019 Aug 2];9. Cancers (Basel) Available from: http://www.ncbi.nlm.nih.gov/pubmed/28085080
- Zöller M. Exosomes in cancer disease. Methods Mol Biol. [Internet]. 2016 [cited 2019 Aug 2]. p. 111–149. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26667458
- Jalalian SH, Ramezani M, Jalalian SA, et al. Exosomes, new biomarkers in early cancer detection. Anal Biochem. [Internet]. 2019 [cited 2019 Aug 2];571:1–13. Available from: https://www.sciencedirect.com/science/article/pii/S0003269718310595
- Xiong G, Feng M, Yang G, et al. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer. Cancer Lett. [Internet]. 2017 Mar 04. 2017;397:94–102. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28254409
- Meng Y, Sun J, Wang X, et al. Exosomes: a promising avenue for the diagnosis of breast cancer. Technol Cancer Res Treat. [Internet]. 2019 [cited 2019 Aug 2];18:153303381882142. Available from: http://journals.sagepub.com/doi/10.1177/1533033818821421
- Theodoraki M, Yerneni S, Gooding WE, et al. Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT. Oncoimmunology. [Internet]. 2019 Jul 3 [cited 2019 Aug 2];8(7):1593805. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31143513
- Nardin C, Cordonnier M, Chanteloup G, et al. Circulating PD-L1-exosomes to monitor tumor response in melanoma patients. J Clin Oncol. [Internet]. 2019 [cited 2019 Aug 2];37:9517. Available from: https://ascopubs.org/doi/10.1200/JCO.2019.37.15_suppl.9517
- Kim J-H, Kim E, Lee MY. Exosomes as diagnostic biomarkers in cancer. Mol Cell Toxicol. [Internet]. 2018 [cited 2019 Aug 19];14:113–122. Available from: http://link.springer.com/10.1007/s13273-018-0014-4
- Makler A, Narayanan R. Mining exosomal genes for pancreatic cancer targets. Cancer Genomics Proteomics. 2017;14:161–172.
- Nedaeinia R, Manian M, Jazayeri MH, et al. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer. Cancer Gene Ther. [Internet]. 2017 [cited 2019 Aug 19];24:48–56. Available from: http://www.nature.com/articles/cgt201677
- Boukouris S, Mathivanan S. Exosomes in bodily fluids are a highly stable resource of disease biomarkers. Proteomics Clin Appl. [Internet]. 2015 [cited 2019 Aug 2];9:358–367. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25684126
- Falcon-Perez J. Exosome profiling: potential in cancer diagnosis and stratification. Endocr Abstr. [Internet]. 2017 [cited 2019 Aug 3]; Available from: http://www.endocrine-abstracts.org/ea/0049/ea0049nsa2.htm
- Fisher R, Pusztai L, Swanton C. Cancer heterogeneity: implications for targeted therapeutics. Br J Cancer. [Internet]. 2013 [cited 2019 Aug 7];108:479–485. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23299535
- Jamal-Hanjani M, Quezada SA, Larkin J, et al. Translational implications of tumor heterogeneity. Clin Cancer Res. 2015;21:1258–1266.
- Seoane J, De Mattos-Arruda L. The challenge of intratumour heterogeneity in precision medicine. J Intern Med. [Internet]. 2014 [cited 2019 Aug 23];276:41–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24661605
- Stanta G, Bonin S. Overview on clinical relevance of intra-tumor heterogeneity. Front Med. [Internet]. 2018 [cited 2019 Aug 7];5:85. Available from: http://journal.frontiersin.org/article/10.3389/fmed.2018.00085/full
- Domenyuk V, Zhong Z, Stark A, et al. Plasma exosome profiling of cancer patients by a next generation systems biology approach. Sci Rep. [Internet]. 2017 [cited 2019 Aug 3];7:42741. Available from: http://www.nature.com/articles/srep42741
- Oliveira-Rodríguez M, López-Cobo S, Reyburn HT, et al. Development of a rapid lateral flow immunoassay test for detection of exosomes previously enriched from cell culture medium and body fluids. J Extracell Vesicles. [Internet]. 2016 [cited 2019 May 30];5:31803. Available from: https://www.tandfonline.com/doi/full/10.3402/jev.v5.31803
- Zhao X, Ren Y, Cui N, et al. Identification of key microRNAs and their targets in exosomes of pancreatic cancer using bioinformatics analysis. Medicine (Baltimore). 2018;97:e12632.
- Cocucci E, Meldolesi J. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol. [Internet]. 2015 [cited 2018 Dec 12];25:364–372. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25683921
- Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. [Internet]. 2013 [cited 2019 Aug 2];200:373–383. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23420871
- Willms E, Johansson HJ, Mäger I, et al. Cells release subpopulations of exosomes with distinct molecular and biological properties. Sci Rep. [Internet]. 2016 [cited 2019 Aug 2];6:22519. Available from: http://www.nature.com/articles/srep22519
- Meldolesi J. Exosomes and ectosomes in intercellular communication. Curr Biol. [Internet]. 2018 [cited 2019 Aug 2];28:R435–R444. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29689228
- van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. [Internet]. 2018 [cited 2019 Aug 2];19:213–228. Available from: http://www.nature.com/articles/nrm.2017.125
- Crescitelli R, Lässer C, Szabó TG, et al. Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles [Internet]. 2013 [cited 2019 Aug 14];2:20677. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24223256.
- Bang C, Thum T. Exosomes: new players in cell–cell communication. Int J Biochem Cell Biol. [Internet]. 2012 [cited 2019 Aug 2];44:2060–2064. Available from: https://www.sciencedirect.com/science/article/pii/S1357272512002853
- S-A S, Xie Y, Fu Z, et al. Emerging role of exosome-mediated intercellular communication in vascular remodeling. Oncotarget. [Internet]. 2017 [cited 2019 Aug 2];8:25700–25712. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28147325
- Mathieu M, Martin-Jaular L, Lavieu G, et al. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. [Internet]. 2019 [cited 2019 Aug 2];21:9–17. Available from: http://www.nature.com/articles/s41556-018-0250-9
- Edgar JR. Q&A: what are exosomes, exactly?. BMC Biol. 2016;14;46. [cited 2019 Apr 15]. Available from http://bmcbiol.biomedcentral.com/articles/10.1186/s12915-016-0268-z
- Maia J, Caja S, Strano Moraes MC, et al. Exosome-based cell-cell communication in the tumor microenvironment. Front Cell Dev Biol. [Internet]. 2018 [cited 2019 Aug 2];6:18. Available from: http://journal.frontiersin.org/article/10.3389/fcell.2018.00018/full
- Wortzel I, Dror S, Kenific CM, et al. Exosome-mediated metastasis: communication from a distance. Dev Cell. [Internet]. 2019 [cited 2019 Aug 2];49:347–360. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31063754
- Tkach M, Théry C. Leading edge review communication by extracellular vesicles: where we are and where we need to go. 2016 cited 2019 Aug 2. doi:10.1016/j.cell.2016.01.043.
- Wan Z, Gao X, Dong Y, et al. Exosome-mediated cell-cell communication in tumor progression. Am J Cancer Res. [Internet]. 2018 [cited 2019 Aug 2];8:1661–1673. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30323961
- Hurley JH. ESCRT complexes and the biogenesis of multivesicular bodies. Curr Opin Cell Biol. [Internet]. 2008 [cited 2019 Aug 2];20:4–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18222686
- Villarroya-Beltri C, Baixauli F, Gutiérrez-Vázquez C, et al. Sorting it out: regulation of exosome loading. Semin Cancer Biol. [Internet]. 2014 [cited 2019 Aug 2];28:3–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24769058
- Tamai K, Tanaka N, Nakano T, et al. Exosome secretion of dendritic cells is regulated by Hrs, an ESCRT-0 protein. biochem. Biophys Res Commun. [Internet]. 2010 [cited 2019 Aug 2];399:384–390. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0006291X10014038
- Colombo M, Moita C, van Niel G, et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci. [Internet]. 2013 [cited 2019 Aug 2];126:5553–5565. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24105262
- Adell MA, Teis D. Assembly and disassembly of the ESCRT-III membrane scission complex. FEBS Lett. [Internet]. 2011 Sep 09. 2011;585:3191–3196. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21924267
- Babst M. MVB vesicle formation: ESCRT-dependent, ESCRT-independent and everything in between. Curr Opin Cell Biol. [Internet]. 2011 [cited 2019 Aug 2];23:452–457. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21570275
- Zhan Y, Du L, Wang L, et al. Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer. Mol Cancer. 2018;17:142. [Internet]. ;:. Available from: https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-018-0893-y
- Zhai L-Y, Li M-X, Pan W-L, et al. In situ detection of plasma exosomal microrna-1246 for breast cancer diagnostics by a au nanoflare probe. acs appl. Mater Interfaces. [Internet]. 2018 [cited 2019 May 7];10:39478–39486. doi:10.1021/acsami.8b12725
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. [Internet]. 2019 [cited 2019 Mar 6];69:7–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30620402
- Hannafon BN, Trigoso YD, Calloway CL, et al. Plasma exosome microRNAs are indicative of breast cancer. Breast Cancer Res. [Internet]. 2016 [cited 2019 Jan 3];18:1–14. doi:10.1186/s13058-016-0753-x.
- Connolly E. Effects of MK-3475 (pembrolizumab) on the breast tumor microenvironment in triple negative breast cancer (pembro/iort) [internet]. ClinicalTrialsGov. United States of America: National Library of Medicine (US). 2016. Available from: https://clinicaltrials.gov/ct2/show/NCT02977468
- Isambert N. Pilot study with the aim to quantify a stress protein in the blood and in the urine for the monitoring and early diagnosis of malignant solid tumors [internet]. ClinicaltrialsGov France: National Library of Medicine (US). 2018; Available from: https://clinicaltrials.gov/show/NCT02662621
- Hydbring P, De Petris L, Zhang Y, et al. Exosomal RNA-profiling of pleural effusions identifies adenocarcinoma patients through elevated miR-200 and LCN2 expression. Lung Cancer. [Internet]. 2018 [cited 2019 May 7];124:45–52. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0169500218304768
- Sun J. Clinical research for the consistency analysis of pd-l1 in lung cancer tissue and plasma exosome before and after radiotherapy [Internet]. China: National Library of Medicine (US). 2016; Available from: https://clinicaltrials.gov/ct2/show/NCT02869685
- Lee C-H, Im E-J, Moon P-G, et al. Discovery of a diagnostic biomarker for colon cancer through proteomic profiling of small extracellular vesicles. BMC Cancer. [Internet]. 2018 [cited 2019 May 7];18:1058. Available from: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-018-4952-y
- Xue X, Zhao Y, Wang X, et al. Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma. J Cell Biochem. 2019;120:135–142.
- Ducreux M, Cuhna AS, Caramella C, et al. Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. [Internet]. 2015 [cited 2018 Nov 26];26:v56–v68. Available from: https://academic.oup.com/annonc/article-lookup/doi/10.1093/annonc/mdv295
- Kaur S, Smith LM, Patel A, et al. A combination of MUC5AC and CA19-9 improves the diagnosis of pancreatic cancer: a multicenter study. Am J Gastroenterol. 2017;112:172–183.
- Wu Z, Kuntz AI, Wadleigh RG. Ca 19-9 tumor marker: is it reliable? A case report in a patient with pancreatic cancer. Clin Adv Hematol Oncol. 2013;11:50–52.
- Melo SA, Luecke LB, Kahlert C, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. [Internet]. 2015 Jun 24. 2015;523:177–182. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26106858
- Zhou C ya, Dong Y ping, Sun X, et al. High levels of serum glypican-1. indicate poor prognosis in pancreatic ductal adenocarcinoma. Cancer Med [Internet]. 2018 [cited 2018 Nov 26]; 7: 5525–5533. .
- Kitagawa T, Taniuchi K, Tsuboi M, et al. Circulating pancreatic cancer exosomal RNAs for detection of pancreatic cancer. Mol Oncol. [Internet]. 2018 [cited 2018 Nov 26]; Available from ;.: http://www.ncbi.nlm.nih.gov/pubmed/30358104
- D’Angelica M, Wieser M A study of imaging, blood, and tissue samples to guide treatment of colon cancer and related liver tumors [Internet]. United States of America: National Library of Medicine (US); 2018. [cited 2020 Jan 6]. Available from: https://clinicaltrials.gov/ct2/show/NCT03432806.
- Yu K, Kelson D A study of blood based biomarkers for pancreas adenocarcinoma [Internet]. United States of America: National Library of Medicine (US); 2017. [cited 2020 Jan 6]. Available from: https://clinicaltrials.gov/ct2/show/NCT03334708.
- Buscail E, Chauvet A, Quincy P, et al. CD63-GPC1-positive exosomes coupled with CA19-9 offer good diagnostic potential for resectable pancreatic ductal adenocarcinoma. Transl Oncol. 2019;12:1395–1403.
- Caivano A, Laurenzana I, De Luca L, et al. High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders. Tumor Biol. 2015;36:9739–9752.
- Cappello F, Logozzi M, Campanella C, et al. Exosome levels in human body fluids: a tumor marker by themselves? Eur. J Pharm Sci. 2017;96:93–98.
- Shah R, Patel T, Freedman JE. Circulating extracellular vesicles in human disease. N Engl J Med. [Internet]. 2018 [cited 2020 Jan 7];379:958–966. doi:10.1056/NEJMra1704286
- Osti D, Del BM, Rappa G, et al. Clinical significance of extracellular vesicles in plasma from glioblastoma patients. Clin Cancer Res. 2019;25:266–276.
- Logozzi M, Angelini DF, Iessi E, et al. Increased PSA expression on prostate cancer exosomes in in vitro condition and in cancer patients. Cancer Lett. 2017;403:318–329.
- Logozzi M, Spugnini E, Mizzoni D, et al. Extracellular acidity and increased exosome release as key phenotypes of malignant tumors. Cancer Metastasis Rev Springer New York LLC. 2019;38:93–101.
- Lea J, Sharma R, Yang F, et al. Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study. Oncotarget. 2017;8:14395–14407.
- Giampieri R, Piva F, Occhipinti G, et al. Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy. PLoS One. Chalmers J, editor. [Internet]. 2019 [cited 2020 Jan 7];14:e0215990. doi:10.1371/journal.pone.0215990
- Zorrilla SR, Pérez-Sayans M, Fais S, et al. A pilot clinical study on the prognostic relevance of plasmatic exosomes levels in oral squamous cell carcinoma patients. Cancers (Basel). 2019;11:429.
- Smith RA, Andrews KS, Brooks D, et al. Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. [Internet]. 2019 [cited 2020 Jan 6];69:184–210. Available from: https://onlinelibrary.wiley.com/doi/abs/10.3322/caac.21557
- Schiffman JD, Fisher PG, Gibbs P. Early detection of cancer: past, present, and future. Am Soc Clin Oncol Educ B. 2015;35:57–65.
- Logozzi M, Angelini DF, Giuliani A, et al. Increased plasmatic levels of psa-expressing exosomes distinguish prostate cancer patients from benign prostatic hyperplasia: a prospective study. Cancers (Basel). 2019;11:1449.
- Barry MJ, Simmons LH. Prevention of prostate cancer morbidity and mortality: primary prevention and early detection. Med Clin North Am WB Saunders. 2017;101:787–806.
- Sharma R, Huang X, Brekken RA, et al. Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies. Br J Cancer. 2017;117:545–552.
- Logozzi M, Mizzoni D, Capasso C, et al. Plasmatic exosomes from prostate cancer patients show increased carbonic anhydrase IX expression and activity and low pH. J Enzyme Inhib Med Chem. [Internet]. 2020 [cited 2020 Jan 7];35:280–288. Available from: https://www.tandfonline.com/doi/full/10.1080/14756366.2019.1697249
- Logozzi M, Capasso C, Di Raimo R, et al. Prostate cancer cells and exosomes in acidic condition show increased carbonic anhydrase IX expression and activity. J Enzyme Inhib Med Chem. 2019;34:272–278.
- Boussadia Z, Lamberti J, Mattei F, et al. Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules. J Exp Clin Cancer Res. 2018;37:245.
- Li P, Kaslan M, Lee SH, et al. Progress in exosome isolation techniques. Theranostics. [Internet]. 2017 [cited 2019 Aug 14];7:789–804. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28255367
- Greening DW, Xu R, Ji H, et al. A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods. Methods Mol Biol. [Internet]. 2015 [cited 2019 Aug 14]. p. 179–209. Available from. ;. http://www.ncbi.nlm.nih.gov/pubmed/25820723
- Konoshenko MY, Lekchnov EA, Vlassov AV, et al. Isolation of extracellular vesicles: general methodologies and latest trends. BioMed Res Int. [Internet]. 2018 [cited 2018 Nov 27];2018:1–27. Available from: https://www.hindawi.com/journals/bmri/2018/8545347/
- Gupta S, Rawat S, Arora V, et al. An improvised one-step sucrose cushion ultracentrifugation method for exosome isolation from culture supernatants of mesenchymal stem cells. Stem Cell Res Ther. [Internet]. 2018 [cited 2019 Aug 14];9:180. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29973270
- Koh YQ, Almughlliq FB, Vaswani K, et al. Exosome enrichment by ultracentrifugation and size exclusion chromatography. Front Biosci (Landmark Ed). [Internet]. 2018 [cited 2019 Aug 14];23:865–874. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28930577
- Van Deun J, Mestdagh P, Sormunen R, et al. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling [Internet]. 2014 [cited 2019 Aug 14];3: 24858. Available from. J Extracell Vesicles. http://www.ncbi.nlm.nih.gov/pubmed/25317274
- Cantin R, Diou J, Bélanger D, et al. Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants. J Immunol Methods. [Internet]. 2008 [cited 2019 Aug 14];338:21–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18675270
- Lobb RJ, Becker M, Wen SW, et al. Optimized exosome isolation protocol for cell culture supernatant and human plasma. J Extracell Vesicles. [Internet]. 2015 [cited 2019 Aug 14];4:27031. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26194179
- Zeringer E, Barta T, Li M, et al. Strategies for isolation of exosomes. Cold Spring Harb Protoc. [Internet]. 2015 [cited 2019 Aug 14];2015:pdb.top074476. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25834266
- Muller L, C-S H, Stolz DB, et al. Isolation of biologically-active exosomes from human plasma. J Immunol Methods. [Internet]. 2014 [cited 2019 Aug 14];411:55–65. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24952243
- Oksvold MP, Neurauter A, Pedersen KW. Magnetic bead-based isolation of exosomes. Methods Mol Biol. [Internet]. 2015 [cited 2019 Aug 14]. p. 465–481. Available from. []:. http://www.ncbi.nlm.nih.gov/pubmed/25319668
- Lobb R, Möller A. Size exclusion chromatography: a simple and reliable method for exosome purification. Methods Mol Biol. [Internet]. 2017 [cited 2019 Aug 14]. p. 105–110. Available from. http://www.ncbi.nlm.nih.gov/pubmed/28828651
- Vaswani K, YQ K, Almughlliq FB, et al. A method for the isolation and enrichment of purified bovine milk exosomes. Reprod Biol. [Internet]. 2017 [cited 2019 Aug 14];17:341–348. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29030127
- Boriachek K, Islam MN, Möller A, et al. Biological functions and current advances in isolation and detection strategies for exosome nanovesicles. Small. [Internet]. 2018 [cited 2020 Jan 8];14:1702153. Available from. [];:. .
- Coumans FAW, Gool EL, Nieuwland R. Bulk immunoassays for analysis of extracellular vesicles. Platelets. [Internet]. 2017 [cited 2020 Jan 9];28:242–248. Available from: https://www.tandfonline.com/doi/full/10.1080/09537104.2016.1265926
- Logozzi M, De Milito A, Lugini L, et al. High levels of exosomes expressing cd63 and caveolin-1 in plasma of melanoma patients. cao Y, editor. PLoS One. [Internet]. 2009 [cited 2020 Jan 7];4:e5219. doi:10.1371/journal.pone.0005219
- Liu C, Xu X, Li B, et al. Single-exosome-counting immunoassays for cancer diagnostics. Nano Lett. 2018;18:4226–4232.
- Khodashenas S, Khalili S, Forouzandeh Moghadam M. A cell ELISA based method for exosome detection in diagnostic and therapeutic applications. Biotechnol Lett. 2019;41:523–531.
- Zhao A, Guo L, Xu J, et al. Identification and validation of circulating exosomes‐based liquid biopsy for esophageal cancer. Cancer Med. [Internet]. 2019 [cited 2020 Jan 9];8:3566–3574. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/cam4.2224
- Erdbrügger U, Lannigan J. Analytical challenges of extracellular vesicle detection: a comparison of different techniques. Cytom Part A. 2016 cited 2020 Jan 9;89:123–134. [Internet]
- Asghar W, Islam M, Wadajkar AS, et al. PLGA micro- and nanoparticles loaded into gelatin scaffold for controlled drug release. IEEE Trans Nanotechnol. [Internet]. 2012 [cited 2019 Aug 28];11:546–553. Available from: http://ieeexplore.ieee.org/document/6123209/
- Asghar W, Ilyas A, Deshmukh RR, et al. Pulsed plasma polymerization for controlling shrinkage and surface composition of nanopores. Nanotechnology. [Internet]. 2011 [cited 2019 Aug 28];22:285304. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21636880
- Coarsey C, Coleman B, Kabir MA, et al. Development of a flow-free magnetic actuation platform for an automated microfluidic ELISA. RSC Adv. [Internet]. 2019 [cited 2019 Aug 28];9:8159–8168. Available from:
- Sher M, Asghar W. Development of a multiplex fully automated assay for rapid quantification of CD4+ T cells from whole blood. Biosens Bioelectron. [Internet]. 2019 [cited 2019 Aug 28];142:111490. Available from: https://www.sciencedirect.com/science/article/pii/S095656631930569X
- Sharma S, Zhuang R, Long M, et al. Circulating tumor cell isolation, culture, and downstream molecular analysis. Biotechnol Adv. [Internet]. 2018 [cited 2019 Aug 28];36:1063–1078. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29559380
- Asghar W, Ilyas A, Billo JA, et al. Shrinking of solid-state nanopores by direct thermal heating. Nanoscale Res Lett. [Internet]. 2011 [cited 2019 Aug 28];6:372. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3211463/
- Asghar W, El Assal R, Shafiee H, et al. Engineering cancer microenvironments for in vitro 3-D tumor models. Mater Today (Kidlington). [Internet]. 2015 [cited 2019 Aug 28];18:539–553. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28458612
- Asghar W, Yuksekkaya M, Shafiee H, et al. Engineering long shelf life multi-layer biologically active surfaces on microfluidic devices for point of care applications. Sci Rep. [Internet]. 2016 [cited 2019 Aug 28];6:21163. Available from: http://www.nature.com/articles/srep21163
- Asghar W, Wan Y, Ilyas A, et al. Electrical fingerprinting, 3D profiling and detection of tumor cells with solid-state micropores. Lab Chip. [Internet]. 2012 [cited 2019 Aug 28];12:2345. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22549275
- Asghar W, Velasco V, Kingsley JL, et al. Selection of functional human sperm with higher DNA integrity and fewer reactive oxygen species. Adv Healthc Mater. [Internet]. 2014 [cited 2019 Aug 28];3:1671–1679. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24753434
- Asghar W, Shafiee H, Velasco V, et al. Toxicology study of single-walled carbon nanotubes and reduced graphene oxide in human sperm. Sci Rep. [Internet]. 2016 [cited 2019 Aug 28];6:30270. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27538480
- Asghar W, Shafiee H, Chen P, et al. In vitro three-dimensional cancer culture models. cancer target. Drug Deliv. [Internet]. New York, NY: Springer New York; 2013 [cited 2019 Aug 28]. p. 635–665. Available from. ;. http://link.springer.com/10.1007/978-1-4614-7876-8_24
- Rappa K, Samargia J, Sher M, et al. Quantitative analysis of sperm rheotaxis using a microfluidic device. Microfluid Nanofluidics. [Internet]. 2018 [cited 2019 Aug 28];22:100. Available from: http://link.springer.com/10.1007/s10404-018-2117-6
- Hammond JL, Formisano N, Estrela P, et al. Electrochemical biosensors and nanobiosensors. Essays Biochem. 2016;60:69–80.
- Fu Z, Lu Y-C, Lai JJ. Recent advances in biosensors for nucleic acid and exosome detection. Chonnam Med J. 2019;55:86.
- Jeong S, Park J, Pathania D, et al. Integrated magneto-electrochemical sensor for exosome analysis. ACS Nano. 2016;10:1802–1809.
- Moura SL, Martín CG, Martí M, et al. Electrochemical immunosensing of nanovesicles as biomarkers for breast cancer. Biosens Bioelectron. 2019;150:111882.
- Doldán X, Fagúndez P, Cayota A, et al. Electrochemical sandwich immunosensor for determination of exosomes based on surface marker-mediated signal amplification. Anal Chem. 2016;88:10466–10473.
- Zhang J, Wang LL, Hou MF, et al. A ratiometric electrochemical biosensor for the exosomal microRNAs detection based on bipedal DNA walkers propelled by locked nucleic acid modified toehold mediate strand displacement reaction. Biosens Bioelectron. 2018;102:33–40.
- Luo L, Wang L, Zeng L, et al. A ratiometric electrochemical DNA biosensor for detection of exosomal MicroRNA. Talanta. 2020;207:120298.
- Liu L, Lu H, Shi R, et al. Synergy of peptide-nucleic acid and spherical nucleic acid enabled quantitative and specific detection of tumor exosomal microRNA. Anal Chem. 2019;91:13198-13205.
- Zhao L, Sun R, He P, et al. Ultrasensitive detection of exosomes by target-triggered three-dimensional DNA walking machine and exonuclease III-assisted electrochemical ratiometric biosensing. Anal Chem. 2019.
- Maduraiveeran G, Sasidharan M, Ganesan V. Electrochemical sensor and biosensor platforms based on advanced nanomaterials for biological and biomedical applications. Biosens Bioelectron. 2018;103:113–129. Elsevier Ltd.
- Fang S, Tian H, Li X, et al. Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification. PLoS One. [Internet]. 2017 [cited 2019 Jan 3];12:e0175050. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28369094
- Savvateeva EN, Tikhonov AA, Butvilovskaya VI, et al. Exosomal surface protein markers in diagnosis of colorectal cancer. Mol Biol. [Internet]. 2017 [cited 2019 Aug 28];51:752–760. Available from: http://www.cellgs.com/Shop/Exosomes/Exosome-Purification-
- Hikita T, Miyata M, Watanabe R, et al. Sensitive and rapid quantification of exosomes by fusing luciferase to exosome marker proteins. Sci Rep. [Internet]. 2018 [cited 2019 Aug 28];8:14035. Available from: http://www.nature.com/articles/s41598-018-32535-7
- Xu H, Liao C, Zuo P, et al. Magnetic-based microfluidic device for on-chip isolation and detection of tumor-derived exosomes. Anal Chem. 2018;90:13451–13458.
- Taller D, Richards K, Slouka Z, et al. On-chip surface acoustic wave lysis and ion-exchange nanomembrane detection of exosomal RNA for pancreatic cancer study and diagnosis. Lab Chip. [Internet]. 2015;15:1656–1666. .
- Salvati E, Stellacci F, Krol S. Nanosensors for early cancer detection and for therapeutic drug monitoring. Nanomedicine. 2015;10:3495–3512. Future Medicine Ltd..
- Li W, Wang H, Zhao Z, et al. Emerging nanotechnologies for liquid biopsy: the detection of circulating tumor cells and extracellular vesicles. Adv Mater. [Internet]. 2019 [cited 2020 Jan 14];31:1805344. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/adma.201805344
- Mathew DG, Beekman P, Lemay SG, et al. Electrochemical detection of tumor-derived extracellular vesicles on nanointerdigitated electrodes. Nano Lett. [Internet]. 2019 [cited 2020 Jan 14];acs.nanolett.9b02741. Available from. ;. https://pubs.acs.org/doi/10.1021/acs.nanolett.9b02741
- Raghu D, Christodoulides JA, Christophersen M, et al. Nanoplasmonic pillars engineered for single exosome detection. PLoS One. 2018;13:e0202773.
- Sina AAI, Vaidyanathan R, Dey S, et al. Real time and label free profiling of clinically relevant exosomes. Sci Rep. 2016;6:30460.
- Lyu Y, Cui D, Huang J, et al. Near-infrared afterglow semiconducting nano-polycomplexes for the multiplex differentiation of cancer exosomes. angew. Chem Int Ed. [Internet]. 2019 [cited 2020 Jan 14];58:4983–4987. .
- Whiteside TL. The potential of tumor-derived exosomes for noninvasive cancer monitoring. Expert Rev Mol Diagn. 2015;15:1293–1310. Taylor and Francis Ltd.
- Braig Z. Personalized medicine: from diagnostic to adaptive. Biomed J 2019. Elsevier B.V..DOI: 10.1016/j.bj.2019.05.004 Elsevier B.V.
- Bernard V, Kim DU, San Lucas FA, et al. Circulating nucleic acids are associated with outcomes of patients with pancreatic cancer. Gastroenterology. [Internet]. 2019 [cited 2019 May 30];156:108–118.e4. Available from: https://www.sciencedirect.com/science/article/pii/S0016508518350066?via%3Dihub
- Imamura T, Komatsu S, Ichikawa D, et al. Liquid biopsy in patients with pancreatic cancer: circulating tumor cells and cell-free nucleic acids. World J Gastroenterol. [Internet]. 2016 Jul 20. 2016;22:5627–5641. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27433079
- Nuzhat Z, Kinhal V, Sharma S, et al. Tumour-derived exosomes as a signature of pancreatic cancer – liquid biopsies as indicators of tumour progression. Oncotarget. 2017;8:17279–17291. [Internet]. ;:. Available from. https://www.ncbi.nlm.nih.gov/pubmed/27999198
- Sisson BA, Uvalic J, Kelly K, et al. Technical and regulatory considerations for taking liquid biopsy to the clinic: validation of the JAX plasmamonitorTM assay. Biomark Insights. 2019;14: 1177271919826545.
- Alvarez Cubero MJ, Lorente JA, Robles-Fernandez I, et al. Circulating tumor cells: markers and methodologies for enrichment and detection. Methods Mol Biol. 2017;1634:283–303. Humana Press Inc..
- Fernando MR, Jiang C, Krzyzanowski GD, et al. New evidence that a large proportion of human blood plasma cell-free DNA is localized in exosomes. PLoS One. 2017;12: e0183915.
- Thakur BK, Zhang H, Becker A, et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 2014;24:766–769. Nature Publishing Group.
- Li A, Zhang T, Zheng M, et al. Exosomal proteins as potential markers of tumor diagnosis. J Hematol Oncol. 2017;10:175 BioMed Central Ltd..
- Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25:981–984. Nature Publishing Group.
- Sauter RE. Exosomes in blood and cancer. Transl Cancer Res. 2017;6:S1316–S1320.
- Gupta RG, Somer RA Intratumor heterogeneity: novel approaches for resolving genomic architecture and clonal evolution. 2017 [cited 2019 Nov 22]; Available from: https://www.aacrjournals.org